Johanna Mercier
Net worth: 18 M $ as of 31/05/2026
Net worth: 18 M $ as of 31/05/2026
Ms. Johanna Mercier is a Chief Commercial Officer at Gilead Sciences, Inc. and a Member at World 50, Inc. She is on the Board of Directors at Neurocrine Biosciences, Inc., Leonard D Schaeffer Center For Health Policy & Economics and Robert Wood Johnson University Hospital, Inc. Ms. Mercier was previously employed as a President-US Commercial by Bristol Myers Squibb Co. She received her undergraduate degree from the University of Montréal and an MBA from Concordia University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/06/2026 | 1,24,234 ( 0.01% ) | 17 M $ | 31/05/2026 | |
| 27/05/2026 | 6,853 ( 0.01% ) | 1 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2019 |
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 15/04/2021 |
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 29/01/2024 |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | - |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson University Hospital, Inc.
Robert Wood Johnson University Hospital, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
World 50, Inc.
World 50, Inc. Internet Software/ServicesTechnology Services Operates as a peer-to-peer platform for business leaders | Technology Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Leonard D Schaeffer Center For Health Policy & Economics
Leonard D Schaeffer Center For Health Policy & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions